Applying the use of novel biomarkers for neuroendocrine tumors in the clinic: where are we now?

被引：2
|
作者：
Daskalakis, Kosmas [1 ]
Norlen, Olov [1 ]
Hellman, Per [1 ]
Stalberg, Peter [1 ]
机构：
[1] Uppsala Univ Hosp, Dept Surg Sci, Endocrine Surg Unit, S-75185 Uppsala, Sweden
来源：
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY | 2019年 / 6卷 / 01期
关键词：
biomarkers; neuroendocrine tumors; prognosis; targeted therapy; PROGNOSTIC MARKERS; CHROMOGRANIN-A; EXPRESSION; ENDOCRINE; DIAGNOSIS; CELLS; LUNG;
D O I：
10.2217/ije-2017-0012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 24 条
  • [1] Biomarkers to detect Wilms tumors in pediatric patients: where are we now?
    Charlton, Jocelyn
    Pavasovic, Vesna
    Pritchard-Jones, Kathy
    FUTURE ONCOLOGY, 2015, 11 (15) : 2221 - 2234
  • [2] Neuroendocrine Gastroenteropancreatic Tumors: Where Are We?
    Ulla Rocha, Jose L.
    Salgado, Angel
    Sardina Ferreiro, Raquel
    Fernandez Catalina, Pablo
    Gallardo, Elena
    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2017, 27 (01) : 36 - 41
  • [3] Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors
    Moris, Dimitrios
    Ntanasis-Stathopoulos, Ioannis
    Tsilimigras, Diamantis I.
    Adam, Mohamad A.
    Yang, Chifu Jeffrey
    Harpole, David
    Theocharis, Stamatios
    CANCER GENOMICS & PROTEOMICS, 2018, 15 (02) : 153 - 163
  • [4] Biomarkers in Psoriasis and Psoriatic Arthritis: Where Are We Now?
    Chandran, Vinod
    Liao, Wilson
    de Vlam, Kurt
    JOURNAL OF RHEUMATOLOGY, 2024, 51 : 74 - 76
  • [5] High-Dose Somatostatin Analogs for the Treatment of Neuroendocrine Neoplasms: where are we Now?
    Alonso-Gordoa, Teresa
    Manneh, Ray
    Grande, Enrique
    Molina-Cerrillo, Javier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (07) : 1001 - 1013
  • [6] Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
    Yokode, Masataka
    Shiokawa, Masahiro
    Kodama, Yuzo
    DIAGNOSTICS, 2021, 11 (05)
  • [7] DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors
    Edfeldt, Katarina
    Daskalakis, Kosmas
    Backlin, Christofer
    Norlen, Olov
    Janson, Eva Tiensuu
    Westin, Gunnar
    Hellman, Per
    Stalberg, Peter
    NEUROENDOCRINOLOGY, 2017, 105 (02) : 170 - 181
  • [8] Blood-Based Biomarkers in Alzheimer Disease: Where Are We Now and Where Have We to Go?
    Laske, Christoph
    JAMA NEUROLOGY, 2013, 70 (01) : 133 - 133
  • [9] Redrawing the Map to Novel DILI Biomarkers in Circulation: Where Are We, Where Should We Go, and How Can We Get There?
    Vazquez, Joel H.
    Mcgill, Mitchell R.
    LIVERS, 2021, 1 (04): : 286 - 293
  • [10] Looking for sputum biomarkers in lung cancer secondary prevention: where are we now?
    Fusco, Nicola
    Fumagalli, Caterina
    Guerini-Rocco, Elena
    JOURNAL OF THORACIC DISEASE, 2017, 9 (11) : 4277 - 4279
123